Chiltern competitors

Colin Shannon is President, Chief Executive Officer (CEO) and Director for PRA. Since 2007, Mr. Shannon has served as President and Chief Operating Officer (COO) for PRA. Mr. Shannon has contributed significantly to the development of PRA's current mission and vision. As COO, he has been instrumental in driving PRA's decision-making processes and building a talented pool of clinical professionals.

Senior Executive and Physician with Biotech, Pharmaceutical and CRO ExperienceBeing both a business leader and a doctor has had a big impact on how I think and work towards integrating social value and financial returns. I also value creativity and curiosity, and I believe these have been instrumental in shaping my approach to problem-solving, scientific analysis, and leadership. My medical training and corporate roles have centered on trying to make a positive impact in healthcare to improve global human health. Right now, our industry faces one of our greatest public health challenges, and I believe it will accelerate progress and flexibility in the way clinical trials are conducted, how innovation in the science of new drugs and therapies is realized, and the way healthcare is delivered with technologies such as telemedicine and wearable devices. One of the highlights of my career was being given the opportunity to lead the clinical trials for the influenza vaccine, FluMist® - a stepping stone that widened my clinical research and drug development experience across a range of therapeutic areas. That’s one reason I feel so connected to Emmes. This Contract Research Organization’s scientists, statisticians and operations teams are passionate about making a positive impact on public health across the world through excellence in clinical research and the development of new life-saving medicines. The work my colleagues at Emmes are doing is truly making a difference in human health, and I’m proud to be leading the company.I’m also grateful to also be able to help startups and emerging businesses in our field by serving as an advisor board member for several biopharmaceutical, clinical research and genomics companies. Staying connected to the local community is important to me as well. I work with nonprofits whose missions I care deeply about. I’m on the board of directors for the Kennedy Center National Symphony Orchestra and a founding board member of Young Women Lead, a non-profit 501c3 organization focused on mentoring and teaching a 21st century leadership EDGE to young women.

Michael Stomberg is a Chief Executive Officer at Planet Pharma and is based in United States.

Bob Loeb MBA is a Chief Financial Officer at Harvard Clinical Research Institute and is based in Boston, Massachusetts. He has worked as Director of Lodging and Resort Operations Revenue Accounting at Copper Mountain, Business Manager at Atrius Health, and Fiscal Director at Harbor Health Services Inc. Bob studied at Bentley University and Syracuse University Martin J. Whitman School of Management.